Cargando…
Development of a novel drug for uncomplicated malaria targeting the mitochondrial NADH:quinone oxidoreductase
Autores principales: | Biagini, Giancarlo A, Hill, Alasdair, Mbekeani, Alison, Shone, Alison, Nixon, Gemma, Stocks, Paul, Gibbons, Peter, Amewu, Richard, Hong, David W, Barton, Victoria, Pidathala, Chandra, Chadwick, James, Le Pensee, Louise, Warman, Ashley, Sharma, Raman, Fisher, Nick, Berry, Neil G, O'Neill, Paul M, Ward, Steve A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963242/ http://dx.doi.org/10.1186/1475-2875-9-S2-O4 |
Ejemplares similares
-
Identification, Design
and Biological Evaluation
of Heterocyclic Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)
por: Leung, Suet C., et al.
Publicado: (2012) -
Identification, Design
and Biological Evaluation
of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2)
por: Pidathala, Chandrakala, et al.
Publicado: (2012) -
A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum
por: Ward, Steve A, et al.
Publicado: (2010) -
The mechanism of catalysis by type-II NADH:quinone oxidoreductases
por: Blaza, James N., et al.
Publicado: (2017) -
A novel cytosolic NADH:quinone oxidoreductase from Methanothermobacter marburgensis
por: Ullmann, Eva, et al.
Publicado: (2014)